Application of novel CAR technologies to improve treatment of autoimmune disease
Chimeric antigen receptor (CAR) T cell therapy has become an important treatment for hematological cancers, and its success has spurred research into CAR T cell therapies for other diseases, including solid tumor cancers and autoimmune diseases.Notably, the development of CAR-based treatments for autoimmune diseases has shown great progress recentl